Carlsmed (CARL) Short Interest Ratio & Short Volume

Short interest is the volume of Carlsmed shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 744,800 shares of CARL short. 7.66% of Carlsmed's shares are currently sold short. Learn More on Carlsmed's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CARL shares currently have a short interest ratio of 4.0. Learn More on Carlsmed's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.66% of Carlsmed's floating shares are currently sold short.

Carlsmed saw a increase in short interest in September. As of September 30th, there was short interest totaling 744,800 shares, an increase of 48.0% from the previous total of 503,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Carlsmed currently has issued a total of 26,580,000 shares. Some of Carlsmed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Carlsmed currently has a public float of 9,720,000 shares.

7.66% of Carlsmed's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Carlsmed: CONMED Corporation (6.69%), SS Innovations International, Inc. (0.31%), BioLife Solutions, Inc. (7.70%), Pulse Biosciences, Inc (20.05%), Kestra Medical Technologies, Ltd. (11.42%), Establishment Labs Holdings Inc. (16.78%), MiMedx Group, Inc (3.19%), InMode Ltd. (4.76%), Tandem Diabetes Care, Inc. (13.73%), Beta Bionics, Inc. (19.48%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($15.71 billion), Robinhood Markets, Inc. ($7.56 billion), Reddit Inc. ($4.55 billion), Coinbase Global, Inc. ($4.53 billion), CoreWeave Inc. ($4.43 billion), Charter Communications, Inc. ($4.07 billion), Seagate Technology Holdings PLC ($3.94 billion), IonQ, Inc. ($3.78 billion), TC Energy Corporation ($3.13 billion), and Live Nation Entertainment, Inc. ($3.12 billion). View all of the most shorted stocks.

Short selling CARL is an investing strategy that aims to generate trading profit from Carlsmed as its price is falling. CARL shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Carlsmed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CARL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARL, twice per month. The most recent reporting period available is September, 30 2025.